Which laboratory tests should be ordered to evaluate renal function, electrolyte disturbances, anemia, and related complications?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 8, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Laboratory Tests for Evaluating Renal Function, Electrolyte Disturbances, Anemia, and Related Complications

Order a comprehensive initial laboratory panel including: complete blood count, serum electrolytes (sodium, potassium, chloride, calcium, magnesium), blood urea nitrogen, serum creatinine with eGFR calculation, urinalysis with urine albumin-to-creatinine ratio, fasting glucose or HbA1c, lipid profile, liver function tests, thyroid-stimulating hormone, serum ferritin, and transferrin saturation. 1, 2

Core Laboratory Panel

The initial evaluation should include:

Renal Function Assessment

  • Serum creatinine and calculated eGFR - Essential for staging CKD and detecting acute kidney injury 1, 3, 4
  • Blood urea nitrogen (BUN) - Helps assess volume status and renal function 1, 5
  • Urinalysis - Screens for proteinuria, hematuria, and other urinary abnormalities 1, 3
  • Urine albumin-to-creatinine ratio (UACR) - Critical for detecting and monitoring diabetic kidney disease; should be measured annually in patients with diabetes or known CKD 3, 4

Electrolyte Panel

  • Sodium, potassium, chloride - Essential for detecting dysnatremias, hyperkalemia/hypokalemia, and acid-base disorders 1, 6, 5
  • Calcium and magnesium - Important as these are frequently abnormal in CKD and can affect cardiac function 1, 2
  • Serum bicarbonate (included in basic metabolic panel) - Screens for metabolic acidosis, common in advanced CKD 3, 5

Anemia Evaluation

  • Complete blood count (CBC) with differential - Provides hemoglobin, hematocrit, mean corpuscular volume, white blood cell count, and platelet count 1, 2, 7
  • Absolute reticulocyte count - Distinguishes between decreased production versus increased destruction/loss 7, 8
  • Serum ferritin - Assesses iron stores 1, 7, 9
  • Transferrin saturation (TSAT) - Evaluates iron availability for erythropoiesis 7, 9

Iron deficiency criteria differ in CKD patients: Absolute iron deficiency is defined as TSAT ≤20% with ferritin ≤100 ng/mL in non-dialysis/peritoneal dialysis patients or ≤200 ng/mL in hemodialysis patients. Functional iron deficiency shows TSAT ≤20% with elevated ferritin 7, 9.

Additional Initial Tests

  • Fasting glucose or HbA1c - Screens for diabetes, a major cause of CKD 1, 2
  • Lipid profile - Assesses cardiovascular risk 1, 2
  • Liver function tests - Rules out hepatic causes of anemia and assesses overall health 1, 2
  • Thyroid-stimulating hormone (TSH) - Thyroid disorders can cause both anemia and electrolyte abnormalities 1, 2

Advanced Testing When eGFR <60 mL/min/1.73 m²

Once CKD stage 3 or higher is identified, add:

  • Serum phosphate - Elevated in CKD, contributes to mineral bone disease 3, 4
  • Parathyroid hormone (PTH) - Screens for secondary hyperparathyroidism 3, 4
  • 25-hydroxyvitamin D - Often deficient in CKD 3, 4
  • Hemoglobin and iron studies - Monitor every 6-12 months for stage 3, every 3-5 months for stage 4, every 1-3 months for stage 5 4

Monitoring Frequency

Serial monitoring is critical and should be tailored to CKD stage:

  • Stage 3 CKD: Every 6-12 months
  • Stage 4 CKD: Every 3-5 months
  • Stage 5 CKD: Every 1-3 months
  • More frequent monitoring needed with therapy changes or symptom development 3, 4

Monitor serum electrolytes and renal function regularly in patients on:

  • ACE inhibitors or ARBs (risk of hyperkalemia and acute kidney injury) 3, 2
  • Diuretics (risk of hypokalemia, hyponatremia, volume depletion) 3, 2
  • SGLT2 inhibitors (monitor for volume depletion, though AKI risk appears low) 3

Specialized Testing - Order Only When Indicated

For Suspected Acute Kidney Injury

  • Urine sodium and chloride - Both should be measured to detect reduced effective intravascular volume; urine sodium <20 mEq/L and chloride <15 mEq/L suggest prerenal azotemia 6, 10, 11
  • Fractional excretion of sodium - Helpful when diuretics not recently administered 10
  • Urine sediment analysis - Identifies casts, cells indicating specific kidney pathology 12

For Unexplained Anemia

  • Vitamin B12 and folate levels - Rule out megaloblastic anemia 7
  • Serum erythropoietin level - Generally not needed; EPO deficiency is expected in CKD 9, 13
  • Hemochromatosis screening or HIV testing - Only in selected patients with clinical suspicion 2

For Diabetic Ketoacidosis or Hyperosmolar State

  • Serum ketones and arterial blood gas - Essential for diagnosis 5
  • Serum osmolality - Calculated or measured 5
  • Anion gap calculation - From basic metabolic panel 5

Critical Pitfalls to Avoid

Do not rely on serum creatinine alone - It lags behind actual GFR changes in acute settings and can be misleading in patients with low muscle mass 3, 12

Do not use standard iron deficiency criteria in CKD patients - Higher ferritin thresholds apply (100-200 ng/mL depending on dialysis status) because inflammation elevates ferritin 7, 9

Do not order 24-hour urine collections for creatinine clearance routinely - Only useful in stable chronic conditions; spot UACR is preferred for albuminuria screening 3, 12

Do not interpret urine electrolytes without considering diuretic use - Diuretics invalidate interpretation of urine sodium for volume assessment 6, 10, 11

Do not forget to check potassium before and after starting RAAS inhibitors - Hyperkalemia is a common and potentially dangerous complication 3, 2

References

Research

Anemia: Evaluation and Diagnostic Tests.

The Medical clinics of North America, 2017

Research

Urine electrolytes and osmolality: when and how to use them.

American journal of nephrology, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.